C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways
Open Access
- 10 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1343
Abstract
Breast carcinoma is the most prevalent cancer in women globally, with complex genetic and molecular mechanisms that underlie its development and progression. Several challenges such as metastasis and drug resistance limit the prognosis of breast cancer, and hence a constant search for better treatment regimes, including novel molecular therapeutic targets is necessary. Complement component 1, q subcomponent binding protein (C1QBP), a promising molecular target, has been implicated in breast carcinogenesis. In this study, the role of C1QBP in breast cancer progression, in particular cancer cell growth, was determined in triple negative MDA-MB-231 breast cancer cells. Depletion of C1QBP decreased cell proliferation, whereas the opposite effect was observed when C1QBP was overexpressed in MDA-MB-231 cells. Furthermore, gene expression profiling and pathway analysis in C1QBP depleted cells revealed that C1QBP regulates several signaling pathways crucial for cell growth and survival. Taken together, these findings provide a deeper comprehension of the role of C1QBP in triple negative breast cancer, and could possibly pave the way for future advancement of C1QBP-targeted breast cancer therapy.Keywords
Funding Information
- Ministry of Education - Singapore (MOE2013-T2-1-129)
This publication has 56 references indexed in Scilit:
- Overexpression of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) in HepG2 Cells Leads to Increased Hyaluronan Synthesis and Cell Proliferation by Up-regulation of Cyclin D1 in AKT-dependent PathwayJournal of Biological Chemistry, 2012
- The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell deathCell Cycle, 2011
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting StrategiesJournal of Biological Chemistry, 2011
- Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate‐specific antigen relapse time after radical prostatectomyCancer Science, 2010
- High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancerBritish Journal of Cancer, 2010
- Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative PhosphorylationMolecular and Cellular Biology, 2010
- Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor StromaCancer Research, 2008
- Cancer Cell CyclesScience, 1996